2020
DOI: 10.1002/ptr.6907
|View full text |Cite
|
Sign up to set email alerts
|

Influence of a low‐dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open‐labeled, active‐controlled clinical trial

Abstract: A 6-week, randomized, open-label, active-controlled clinical trial was conducted to evaluate the influence of a low-dose curcumagalactomannosides (CGM) (400 mg once daily) in OA subjects. The treatment was compared with a standard combination of 500 mg glucosamine hydrochloride (GLN) and 415 mg chondroitin sulphate (CHN), supplied as a single oral dose twice a day. Out of 84 subjects randomized, 72 subjects who have completed the study were evaluated for the safety and efficacy of the treatments at baseline an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 25 publications
(19 citation statements)
references
References 48 publications
0
16
0
3
Order By: Relevance
“…Many studies demonstrated that oral administration of CS improved human knee joint pains [ 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 ]. Even though glucosamine has been commercialized as a dietary supplement, oral CS bioavailability remains speculative, and conflicting results are found in the scientific literature.…”
Section: Prospective Pharmacological Applicationmentioning
confidence: 99%
“…Many studies demonstrated that oral administration of CS improved human knee joint pains [ 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 ]. Even though glucosamine has been commercialized as a dietary supplement, oral CS bioavailability remains speculative, and conflicting results are found in the scientific literature.…”
Section: Prospective Pharmacological Applicationmentioning
confidence: 99%
“…After screening the titles and abstracts of the remaining 263 citations, we excluded 233 irrelevant records based on the selection criteria. Thirty studies were remained for full-text assessment, eleven studies were excluded because of ineligible interventions, including the combination of glucosamine hydrochloride, chondroitin sulphate and curcumin [ 41 ], curcumagalactomannoside complex [ 42 , 43 ], CURs combined with diclofenac [ 44 , 45 ], herbal formulations of different extracts [ 46 50 ], and CURs-free CL extracts [ 51 ]. Furthermore, we excluded four conference abstracts [ 52 – 55 ] due to incomplete data.…”
Section: Resultsmentioning
confidence: 99%
“…After screening the titles and abstracts of the remaining 291 citations, we excluded 262 irrelevant records based on the selection criteria. Twentynine studies were remained for full-text assessment, eleven studies were excluded because of ineligible interventions, including the combination of glucosamine hydrochloride, chondroitin sulphate and curcumin [42], curcumagalactomannoside complex [43,44], CURs combined with diclofenac [45,46], herbal formulations of different extracts [47][48][49][50][51], and CURs-free CL extracts [52]. Furthermore, we excluded four conference abstracts [53][54][55][56] due to incomplete data.…”
Section: Literature Search Resultsmentioning
confidence: 99%